Stabilization of metastatic myxopapillary ependymoma with sorafenib

16Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We report on a 59-year old woman with three huge intrathoracal masses that were accidentally diagnosed when she consulted a physician for upper abdominal discomfort. A biopsy revealed that they were metastases of a coccygeal myxopapillary ependymoma, resected 20 years before. As neither resection, debulking, nor radiation therapy were considered to be indicated, systemic therapy with temozolomide was started. At the first evaluation after four months, the metastases had progressed. Imatinib delayed the progression, but had to be stopped after six months because of critical increased pleural effusion. Using the multikinase inhibitor sorafenib, the disease was stabilized and an acceptable quality of life could be obtained for one year. © G. Fegerl and C. Marosi, 2012 Licensee PAGEPress, Italy.

Cite

CITATION STYLE

APA

Fegerl, G., & Marosi, C. (2012). Stabilization of metastatic myxopapillary ependymoma with sorafenib. Rare Tumors, 4(3), 134–137. https://doi.org/10.4081/rt.2012.e42

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free